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Moderators and mediators can be very informative in the analysis of
clinical trials to help determine what treatment should be assigned to individ-
uals (moderators) and to determine how to improve treatments (mediators).
It is well known that a treatment might not be equally beneficial to everyone
and an overall effective treatment may be less effective (or even harmful) in
certain groups; this highlights the importance of moderators in making treat-
ment assignment decisions. A combined moderator, or optimal moderator,
can be useful when multiple potential moderators exist, but no individual one
is particularly strong. This report reviews how to assess a single moderator
as well as approaches to derive an optimal moderator. An example from ran-
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Chapter 1
Introduction: A Brief Review of Moderators
and Mediators
Consider a single-blind, multi-site, randomized controlled trial (RCT)
with outcome O and two treatments T (T1 and T2), and the baseline variable
M . M is a moderator if it helps explain under which circumstances that T is
related to O while M is a mediator if it helps explain how or why T is related
to O (Baron and Kenny, 1986).
Differences and similarities between moderators and mediators were
further discussed in Kraemer et al. (2013). More specifically, M is a moderator
if it is uncorrelated with T and the correlation between T and O differs by
M . On the other hand, M is a mediator if it is correlated with T and the
correlation between T and O can be partly explained by the effect of T on M .
The relationship among T , M , and O in these two cases are shown in Fig 1.1.
From the definition above, a variable cannot be both a moderator and
mediator. Moderators help determine which group of patients should receive
which treatment to optimize the outcome, and mediators explores how a treat-
ment works on the outcome so that it is feasible to improve or remove some
treatment to make it more effective or cost less. Baseline covariates are poten-
1
Figure 1.1: (a)Moderation of M on T and O ; b)Mediation of M on T and O
tial moderators, since by randomization, they are uncorrelated with treatment.
In this report, we focus on the moderators to choose a suitable treat-
ment for different groups of patients in order to benefit them. Chapter 2
introduces the effect size calculation and measurement for a single moderator,
based on a linear regression approach with interaction term included. Chapter
3 discusses methods to obtain an optimal moderator when multiple potential
moderators exist, to strengthen the moderation as well as make it more conve-
nient for treatment assignment decisions. Moderators and optimal moderators
are implemented by an example in Chapter 4, where the data from an RCT is
used and several baseline covariates are primarily selected and discussed.
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Chapter 2
Parametric approach for accessing moderators




The term effect size generally refers to a statistic which measures the
strength of a treatment effect. One of the advantages of effect size measure-
ment is that it does not depend on the sample size of the data, which is quite
different than that of the traditional significance testing. Note that effect size
is typically standardized if outcomes and independent variables are measured
on different scales, or the results come from different experiments.
According to the website of Becker, these methodologies can be sum-
marized into two ways to measure effect size:
1. Using standardized difference between two means
2. Using effect size correlation
The effect size correlation is the correlation between the independent
variable and the dependent variable, such as outcome (Rosnow & Rosen-
thal, 1996).
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In terms of using standardized difference between two group of means,
Cohen
′
s d (Cohen, 1988) is a typical method. Define d as the standardized
difference of two means, during the process of which either standard devia-
tion of the two groups can be used if the variation from the two groups is









where M1, M2, M are two group means and overall mean respectively, X is
group, and n observations; d denotes Cohen
′
s d.
In practice, it is common to apply σpooled as the pooled standard de-
viation calculated from two independent groups. Cohen
′







(n1 − 1)s21 + (n2 − 1)s22






(mi,j −Mi)2, i = 1, 2,
where n1 and n2 are the number of data for each group, and mi,j are the
observed data from each group i, i=1,2.
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On the other hand, considering using effect size correlation, it is quite
common to use Pearson product-moment correlation as the value of effect size
correlation. Suppose X denotes the independent variable and Y denotes the












2.1.2 Interpretation of Effect Size and Cohen
′
s d
Based on the definition from Cohen (1988), there are three levels of the
strength for effect size:
1. d = 0.2, small
2. d = 0.5, medium
3. d = 0.8, large
Effect size can be viewed as the percent of nonoverlap of the one treat-
ment group’s scores with those of another treatment group. For example, d =
5
0.0 shows that there is 0 percent of nonoverlap between the two treatments, or
we could say the two groups overlap completely. d = 0.5 indicates that there
is 33.0 percent of nonoverlap between two treatment groups. d = 0.8 states
that there is 47.4 percent of nonoverlap between two treatment groups. Note
that d can be greater than 1 but the percent of nonoverlap should stay betwen
0 and 1.
2.2 Moderator effect size
Linear regression models are an effective and popular approach to de-
termine whether a variable is a moderator or not. Let O denote the outcome
variable, and T represent treatment. The linear regression model is
O = b0 + b1T + b2M + b3T ∗M + ε. (2.1)
Note that interaction term allows the treatment to have a different effect on
the outcome depending on M . M can be either continuous or categorical, and
the interaction term T ∗M is of primary interest. The error term ε, which is
independent of treatment and M , follows a normal distribution, N(0, σ2).
To interpret the coefficients of linear model above, b0 is the intercept;
b1, the main effect; b2, the effect of M ; and b3, the interaction effect of T under
M .
To be specific, there are three possible cases for M : non-predictor,
predictor but non-moderator, and moderator. These are detailed in the expla-
nation and figures below. In the figure, the x-axis denotes M and the y-axis,
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the outcome. The vertical distance between two lines indicates the effect size
difference between the two treatments at a certain value of M .
1. M: Non-predictor in both treatment groups (T1 and T2)
The linear regression model is
O = b0 + b1T + (0×M + 0× T ∗M) + ε
= b0 + b1T + ε.
It is the simplest model where the interpretation of coefficients is s-
traightforward. Since there is no effect of M , b1 shows the amount change
of outcome on average for the change in treatments. Also, see Figure
2.1.
2. M: Predictor but non-moderator in both treatment groups (T1
and T2)
Now suppose that T1 responds to a higher level of the outcome then
T2 by M . In this case, it is shown in Fig 2 that the difference in the
outcome between T1 and T2 is constant under M . That means, M is
a predictor of the outcome under both treatments, but the effect size is
the same for all values of M . Then the linear regression model is:
O = b0 + b1T + b2M + (0× T ∗M) + ε
= b0 + b1T + b2M + ε.
Here b2 represents the main effect of M , which is additive to the effect
of treatment, b1.
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3. M: Moderator in both treatment groups (T1 and T2)
Another scenario occurs when T1 has a steeper M-outcome curve than
T2, or vice versa (Fig 2.3 and Fig 2.4). In both cases, the effect size
of treatment changes; thus M is a Moderator.The true linear regression
model is:
O = b0 + b1T + b2M + b3T ∗M + ε.
This is a more complex model since there are interaction effects between
treatment and moderator on the outcome. b3 represents the slope differ-
ences of the two line, T1 and T2. The effect of treatment on O is b1 +
b3M .
Figure 2.1: M Non Predictor
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Figure 2.2: M Predictor Non Moderator
Figure 2.3: M Moderator Case 1
9
Figure 2.4: M Moderator Case 2
2.3 Single Moderator Calculation
Some have suggested using the interaction term T ∗M to measure the
effect of moderation. However this can be problems since when M = −b1/b3,
the effect of treatment on O is 0. b3 itself could not be moderator effect size
mainly because when the measurement scale of O changes, the value of effect
size will change accordingly while the real effect doses not actually change.
Some modifications on b3 can be applied to solve the problem, such
as using the standardized coefficient di = bi/σ̂
2 instead, where i = 1, 2, 3
and σ̂2 is the unbiased estimator for the variance of residuals. However, it is
also unsatisfactory . There may be other relevant true moderators which are
omitted from the model, and hence the moderator we focus on may not be the
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moderator but happens to correlate with those omitted variables. The example
used is that, if gender is treated as a moderator, the true moderator might be
height, weight, or income. As a result, without introducing an instrumental
variable, it is hard to determine whether the ’moderator’ is a true moderator
or just proxy one.
2.3.1 Moderator Effect size approach
According to the drawbacks, a moderator effect size method is utilized
to test moderation in general case. It is plausible to consider the pairwise
difference between randomly selected patients from T1 and T2 respectively,
because the moderator will identify different outcome effects (O1 − O2) of
treatment groups on individuals.
We code T1 and T2 as -0.5 and 0.5 respectively, and we use the stan-
dardized coefficients di instead of original coefficients bi. M is also scaled to
have mean 0 and variance 1. Based on Equation 2.1, we have the outcome
difference as
4O = O1 - O2 = b1 + b2(M1 - M2) + b3(M1 + M2)/2 + (ε1 - ε2)
Define the average and difference effect as AM and DM, written as
AM = (M1 +M2)/2
DM = (M1 −M2)
Since M1 and M2 come from the same distribution and AM and DM













E(4O) = b1 + b2E(DM) + b3E(AM)/2 = b1
V ar(AM) = 1/2
V ar(4O) = 2b22 + b23/2 + 2σ2
Cov(4O,AM) = E(4O × AM) = b3E(AM)2/2 = b3/4.












E(4O) = b1 + b2E(DM) + b3E(AM)/2 = b1
V ar(DM) = 2
V ar(4O) = 2b22 + b23/2 + 2σ2
Cov(4O,DM) = E(4O ×DM) = b2E(DM)2 = 2b2.
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2.3.2 Measurement on Moderator Effect Size
Based on the discussion in Section 2.1.2, it is reasonable to determine
the type of M using r(4O,AM) and r(4O,DM), whose ranges are both from
-1 to 1, with a larger absolute value indicating a stronger moderator effect.
Cohen
′
s d can be re-formulated using r(4O,AM) and r(4O,DM) and










where d1 is the main effect of treatment, the Cohen
′
s d computing the differ-
ence between T1 and T2 at M=0. It is easy to see that
Cohen
′
s d = d1(1− r(4O,AM)2 − r(4O,DM)2),
which is an equivalent formula with the previous definition. We now restate
the three types of M based on the correlations:
1. M: Non-predictor in both treatment groups (T1 and T2)
If r(4O,AM) = r(4O,DM) = 0, then it means M is non-predictor in
both treatment groups, as is shown in Fig 2.1 . Cohen
′
s d is constant.
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2. M: Predictor but non-moderator in both treatment groups (T1
and T2)
If r(4O,AM) = 0 but r(4O,DM) 6= 0, then it means M is a predictor
but non moderator in both treatment groups, and the treatment effect is
the same for any value of M , as is shown in Fig 2.2. Cohen
′
s d is smaller
than d1, because M increases the within group variance, hence reducing
the nonoverlap of the two groups.
3. M: Moderator in both treatment groups (T1 and T2)
However, if r(4O,AM) 6= 0 , then it means M is a moderator in both
treatment groups, and the effect size differs as M varies. Possible cases
are shown in Fig 2.3 and Fig 2.4. Cohen
′
s d and d1 are not satisfac-
tory to show the treatment effect size within the population and thus
r(4O,AM) plays an important role in interpreting the moderator effect




3.1 Optimal Moderator Approach
The moderator effect size can be applied to detect the existence and
strength of moderation based on r(4O,AM). For a single moderator, the
bootstrap might be used to construct a confidence interval for r(4O,AM).
However, if there are multiple moderators, based on moderator effect size
tests, it is appealing to find an optimal moderator by combining those multiple
moderators.
It is better to search for an optimal moderator instead of individual
ones mainly because individual moderators can be all weak while the optimal
one may provide strong moderation. In addition, without combining multiple
moderators, it can be confusing to determine treatment according to separate
individual moderators since they may be conflicting. The multiple moderators
should be primarily focused on baseline variables, based on which the outcomes
differ between treatment effects. Two different methods will be introduced to
search and build an optimal moderator.
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3.2 Development of an Optimal Moderator
3.2.1 Principal Component regression
Suppose M = (M1, . . . ,Mp) represent p potential individual moder-
ators which have been standardized. To find the optimal moderator out of
multiple moderators, it is equivalent to seek for optimal linear combination
of α
′
M for some vector α so as to maximize the interaction term b3 in the
following equation:
O = b0 + b1T + b2(α
′
M) + b3T ∗ (α
′
M) + ε (3.1)
Let ΦM = HDH
′
denote the covariance matrix of M, where D is di-
agonal matrix of eigenvalues and H is orthogonal matrix. Define ΦMO1 and
ΦMO2 to be the vector covariances between the outcomes and the p moderators
corresponding to each treatment. Using principle component regression, the





(ΦMO1 − ΦMO2)(ΦMO1 − ΦMO2)
′
HD−1/2 (3.2)








M , where α? denotes new matrix formed by selected eigenvectors
whose corresponding eigenvalues of A are positive. In this way the optimal
moderator is defined.
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3.2.2 Regression Weights Based on Randomly-Paired Treatment
Groups
In what follows are the steps for another approach to construct an
optimal moderator:
1. Eliminating multicollinearity among multiple moderators
Since the number of potential moderators may not be too small, multi-
collinearity problem can occur. Hence principal component analysis on
all the baseline moderators turns to be a simple way to eliminate mul-
ticollinearity, and just select probable moderators whose eigenvalues are
larger than 1.
2. Calculating weights by regression on randomly-paired treat-
ment groups
From the original data set, suppose the two treatments are T1 and T2
with N1 and N2 units respectively. A new data set is constructed by
randomly pairing every unit in N1 group with every unit in N2 group,
to get the final N1×N2 pairs in total. Thus the linear regression model
is built as
4O = O1 −O2 ∼ AMi
where 4O is the outcome difference on each pairs between two treat-
ments, and AMi = (Mi1 + Mi2)/2 representing for the mean of every
selected moderator variable for each pair. Each of the regression coeffi-
cients is then the weight, wi, corresponding to the each potential moder-
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ator from the linear model. Denote the optimal moderator by M?. For




3. New effect size for M?
Similar to the earlier approach, but using the optimal moderator M?
instead, the new effect size can be calculated by the linear regression
model below
O = b0 + b1T + b2M
? + b3T ∗M? + ε. (3.3)
Using di as the standardized coefficient, the optimal moderator effect











The data comes from the study, approved by the University of Florida
Institutional Review Board and delivered via Cooperative Extension Offices,
of lifestyle interventions in treating rural obesity. An RCT was performed
to determine the effects of three levels of behavioral lifestyle treatments in
comparison to a control level with nutrition education, based on 6-month and
24-month body weight changes.
For convenience of the moderation analysis, we focused on the percent
weight change as primary outcome from 0-month (baseline) to 6-month only,
and combined the control condition (SLOW) and low level of treatment (LOW)
as Treatment 1 (T1) while the moderate (MOD) and high (HIGH) levels as
Treatment 2 (T2). T1 mainly involved deliveries of instructive information
and lectures in healthy diet and appropriate physical exercise together with
corresponding group discussions. T2 included the same contents of interven-
tion at a higher delivery rate and extra behavior care such as goal setting and
material incentive. This grouping method is reasonable in that the percent
weight changes together with their 95% percent Confidence Interval for each
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two treatments within T1 and T2 are close, in the period from baseline to
6-month (Table 1).
SLOW(n=169) LOW(n=148) Moderate(n=134) High(n=161)
6-month 4.1 (3.1 to 5.1) 7.2 (6.1 to 8.3) 9.3 (8.2 to 10.3) 10.9 (9.8 to 11.9)
Table 4.1: Percent of Weight Loss in 6-month
From ten rural counties in northern Florida, 1072 adults who responded
to study announcements and met eligible criteria were screened. 460 of them
were excluded due to failure in participation or medical eligibility and hence
the rest 612 adults were selected and randomly assigned to T1 and T2 (Figure
4.1). Those participants were all in age between 21 and 75, with a body-mass
index (BMI, kg/m2) between 30 and 45, and had weight changes less than 4.5
kg in the previous 6 months.
4.2 Results and Interpretations
In order to determine individual moderators among all the baseline
variables, as well as to find the optimal moderator if multiple moderators exist,
the method of regression weights on Randomly-Paired Treatment Groups was
applied to explore moderation here.
First we selected 10 baseline variables to be included in the model,
after centering and scaling. Among these 10 baseline variables which are
shown in Table 4.2, 400m-walk-time means the time used to walk 400 me-
ters; BAECKEAF0, the Baecke questionnaire; and the other eight, quality
20
 2879 responded and 
received phone inquires 
1072 screened on site 
612 randomly selected and 
assigned to two interventions 
295 assigned to 
Treatment 2 
284 accessed at Month 6 
(96.3%) 
295 included in primary 
analysis  
  8 declined or no longer available 
  3 pregnant 
 
317 assigned to 
Treatment 1 
300 accessed at Month 6 
(94.6%) 
317included in primary 
analysis  
 14 declined or no longer  available        
  2  pregnant 
  1  joined other diet program 
 460 excluded: 
 121 declined participation 
 339 failed to meet certain standard such as       
        BMI, blood pressure,  recent weight  change, or  
        screening results   
 1366  failed to meet eligibility criteria 
 441    rejected to attend screening on site 
Figure 4.1: Participant flow from screening, random assignment, to follow-up
in first 6 month
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of life scales. The moderator effect size r(4O,AM) was calculated for each
potential moderator and 8 of them were selected in calculating the combined
moderator, with the other 2 deleted due to a low effect size (<0.01). We
skipped the principle component analysis step here. The single moderator
effect sizes are also shown in Table 4.2, from which we could tell that none
of the 8 potential individual moderators had an effect size greater than 0.07.
Thus, a combined multiple moderator would be desirable to increase strength
and power of the moderation.
The Next step is to determine the weight of each individual moderator
in the optimal one based on regression coefficients in Randomly-Paired Treat-
ment Group. We constructed a new data set with Randomly-paired group
from each treatment omitting the missing data, to get 40170 pairs in total,
with dependent variable 4O = O1 − O2 for every pair, and eight potential
moderators. Then the regression coefficients represent the weights (w) for the
combined multiple moderators we computed (see Table 4.2).
After computing the weights, we construct an optimal moderator M?
by multiplying each potential moderators with their weights and then adding
those terms together. The moderator effect size is -0.148 with 95% CI as
[−0.149,−0.145], which is much stronger than the individual effect size. The
95% CI seems kind of narrow which may be relative to the sample size.
To interpret the results, we look at the plot in Figure 4.2 where the
percent of weight loss given M? for T1 and T2 is shown. In the figure, the
regression line for T1 interacts with that of T2 at a cross point for M? = 2.66.
22






SFV T0 -0.02 0.62
SFSF0 0.06 -1.40
SFMH0 -0.07 0.84
400m− walk − time -0.01 0.58
Ignored Moderator
with low effect size
BAECKEAF0 -0.005
SFRFE0 -0.006
Table 4.2: Single Moderator Effect Sizes and Weights in Combined (Optimal)
Moderator
Since in the left part of the cross point (or line), the line of T2 is above T1,
suggesting that T2 is better than T1 in weight loss while in the right part, T1
is above and hence more preferable than T2. Thus, based on the value of M?,
we may implement different treatments on different people to achieve a better
outcome.
In practice, when M? is smaller than 2.66, then T2 is more desirable
while on the other hand, when M? is greater than 2.66, T1 is more desirable.
Looking back to the data, only two participants have M? greater than 2.66.
Thus, we could probably not recommend T1 for anyone here.
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Figure 4.2: Moderation on T1 and T2
4.3 Discussion
This report discussed the methodology of individual moderator effec-
t size calculation together with possible combined multiple moderators ap-
proach, using an RCT of weight loss for illustration. Moderation should be
carefully considered in clinical treatments since it might reflect better the de-
sire of different treatments from different patient groups. Moreover, the opti-
mal moderator, which is calculated based on multiple moderator combination,
holds a meaningful approach to the quantitative measure on judging which
treatment is more preferable. It also account for most of the information from
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individual moderators and provides simple guide for treatment selection.
However, there are some issues with the approach that was used. First,
the weights we calculate in the combination dose not reflect the strength of
moderation; that is, a moderator with small weight can still have a strong
individual moderation. Second, moderators and optimal moderator are based
on the selection of baseline variables, which is dependent on the missingness of
the data and the elimination of multicollinearity among those variables. When
facing lots of potential moderators, they should be fairly considered. Third,
there are still many other ways to calculate the optimal moderator M? and the
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